UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data

PloS one, 2021-12, Vol.16 (12), p.e0261983-e0261983

2021

Link zum Volltext

Verfügbarkeit prüfen

Transplantation of human iPSC-derived muscle stem cells in the diaphragm of Duchenne muscular dystrophy model mice

PloS one, 2022-04, Vol.17 (4), p.e0266391-e0266391

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential effects of temperature and mTOR and Wnt-planar cell polarity pathways on syndecan-4 and CD44 expression in growth-selected turkey satellite cell populations

PloS one, 2023-02, Vol.18 (2), p.e0281350-e0281350

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparative analysis of the myoglobin gene in whales and humans reveals evolutionary changes in regulatory elements and expression levels

PloS one, 2023-08, Vol.18 (8), p.e0284834-e0284834

2023

Link zum Volltext

Verfügbarkeit prüfen

Necroptosis mediates myofibre death in dystrophin-deficient mice

Nature communications, 2018-09, Vol.9 (1), p.3655-10, Article 3655

2018

Link zum Volltext

Verfügbarkeit prüfen

Predictive models in SMA II natural history trajectories using machine learning: A proof of concept study

PloS one, 2022-05, Vol.17 (5), p.e0267930-e0267930

2022

Link zum Volltext

Verfügbarkeit prüfen

Quantitative assessment of sitting time in ambulant adults with Muscular Dystrophy

PloS one, 2021-11, Vol.16 (11), p.e0260491-e0260491

2021

Link zum Volltext

Verfügbarkeit prüfen

Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy

Frontiers in genome editing, 2022-07, Vol.4, p.937879-937879

2022

Link zum Volltext

Verfügbarkeit prüfen

Age-Associated Methylation Suppresses SPRY1, Leading to a Failure of Re-quiescence and Loss of the Reserve Stem Cell Pool in Elderly Muscle

Cell reports (Cambridge), 2015-11, Vol.13 (6), p.1172-1182

2015

Link zum Volltext

Verfügbarkeit prüfen

Exosomes in Ageing and Motor Neurone Disease: Biogenesis, Uptake Mechanisms, Modifications in Disease and Uses in the Development of Biomarkers and Therapeutics

Cells (Basel, Switzerland), 2021-10, Vol.10 (11), p.2930

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy

International journal of molecular sciences, 2018-05, Vol.19 (5), p.1347

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic Evidence That Captured Retroviral Envelope syncytins Contribute to Myoblast Fusion and Muscle Sexual Dimorphism in Mice

PLoS genetics, 2016-09, Vol.12 (9), p.e1006289

2016

Link zum Volltext

Verfügbarkeit prüfen

Transiently expressed CRISPR/Cas9 induces wild-type dystrophin in vitro in DMD patient myoblasts carrying duplications

Scientific reports, 2022-03, Vol.12 (1), p.3756-3756, Article 3756

2022

Link zum Volltext

Verfügbarkeit prüfen

Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy

Journal of cachexia, sarcopenia and muscle, 2020-06, Vol.11 (3), p.768-782

2020

Link zum Volltext

Verfügbarkeit prüfen

Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity

Proceedings of the National Academy of Sciences - PNAS, 2009-05, Vol.106 (18), p.7479-7484

2009

Link zum Volltext

Verfügbarkeit prüfen

RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy

Journal of cachexia, sarcopenia and muscle, 2021-12, Vol.12 (6), p.2079-2090

2021

Link zum Volltext

Verfügbarkeit prüfen

Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy

PLoS genetics, 2013-06, Vol.9 (6), p.e1003550-e1003550

2013

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Strategies Targeting DUX4 in FSHD

Journal of clinical medicine, 2020-09, Vol.9 (9), p.2886

2020

Link zum Volltext

Verfügbarkeit prüfen

A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy

Molecular therapy. Nucleic acids, 2020-12, Vol.22, p.1191-1199

2020

Link zum Volltext

Verfügbarkeit prüfen

Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases

Human molecular genetics, 2014-08, Vol.23 (15), p.4125-4133

2014

Link zum Volltext

Verfügbarkeit prüfen

DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation

Journal of personalized medicine, 2020-09, Vol.10 (3), p.73

2020

Link zum Volltext

Verfügbarkeit prüfen

Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy

Annals of neurology, 2015-09, Vol.78 (3), p.387-400

2015

Link zum Volltext

Verfügbarkeit prüfen

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?

Journal of personalized medicine, 2020-12, Vol.11 (1), p.7

2020

Link zum Volltext

Verfügbarkeit prüfen

The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger Subtypes

Cells (Basel, Switzerland), 2022-03, Vol.11 (5), p.845

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(64)

Sprache

Englisch
(64)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Life Sciences & Biomedicine
(37)
Humans
(33)
Life Sciences
(17)
Animals
(15)
Muscular Dystrophy
(14)
Mice
(12)
Multidisciplinary Sciences
(12)
Science & Technology - Other Topics
(12)
Genetics
(10)
Muscular Dystrophy, Facioscapulohumeral - Genetics
(10)
Female
(9)
Genetics & Heredity
(9)
Genomics
(9)
Molecular Biology
(9)
Mutation
(9)
Proteins
(9)
Biochemistry, Molecular Biology
(8)
Biology And Life Sciences
(8)
Dystrophy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data

Transplantation of human iPSC-derived muscle stem cells in the diaphragm of Duchenne muscular dystrophy model mice

A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice

Differential effects of temperature and mTOR and Wnt-planar cell polarity pathways on syndecan-4 and CD44 expression in growth-selected turkey satellite cell populations

Comparative analysis of the myoglobin gene in whales and humans reveals evolutionary changes in regulatory elements and expression levels

Necroptosis mediates myofibre death in dystrophin-deficient mice

Predictive models in SMA II natural history trajectories using machine learning: A proof of concept study

Quantitative assessment of sitting time in ambulant adults with Muscular Dystrophy

Gene Editing to Tackle Facioscapulohumeral Muscular Dystrophy

Age-Associated Methylation Suppresses SPRY1, Leading to a Failure of Re-quiescence and Loss of the Reserve Stem Cell Pool in Elderly Muscle

Exosomes in Ageing and Motor Neurone Disease: Biogenesis, Uptake Mechanisms, Modifications in Disease and Uses in the Development of Biomarkers and Therapeutics

Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy

Genetic Evidence That Captured Retroviral Envelope syncytins Contribute to Myoblast Fusion and Muscle Sexual Dimorphism in Mice

Transiently expressed CRISPR/Cas9 induces wild-type dystrophin in vitro in DMD patient myoblasts carrying duplications

Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy

Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity

RIPK3‐mediated cell death is involved in DUX4‐mediated toxicity in facioscapulohumeral dystrophy

Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy

Therapeutic Strategies Targeting DUX4 in FSHD

A Deoxyribonucleic Acid Decoy Trapping DUX4 for the Treatment of Facioscapulohumeral Muscular Dystrophy

Nuclear protein spreading: implication for pathophysiology of neuromuscular diseases

DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation

Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy

Gene Editing Targeting the DUX4 Polyadenylation Signal: A Therapy for FSHD?

The Neurotoxicity of Vesicles Secreted by ALS Patient Myotubes Is Specific to Exosome-Like and Not Larger Subtypes

Suchergebnisse filtern